Lenz & Staehelin advised Asceneuron in its Series C financing. Asceneuron SA, a clinical stage biotech company developing small molecules targeting tau protein aggregation, a root...
You must be a Standard 1 Year member to access this content.
Lenz & Staehelin has advised Volumina Medical in this financing round. Volumina Medical, a clinical stage MedTech company developing novel biomaterials for dermatology and plastic surgery,...
You must be a Standard 1 Year member to access this content.
Lenz & Staehelin advised Transmutex on all legal matters. Transmutex SA, a nuclear engineering company based in Geneva, Switzerland, raised over CHF 20M in the extension...
You must be a Standard 1 Year member to access this content.
